Revvity Launches GSP T1D 3plex Kit for Early Type 1 Diabetes Screening in Children

Revvity has launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified multiplex autoantibody detection solution designed to support population-level screening programmes for children at risk of developing type 1 diabetes (T1D) months or even years before clinical symptoms appear. The T1D screening kit will initially be available across Europe and in markets that accept […]

The post Revvity Launches GSP T1D 3plex Kit for Early Type 1 Diabetes Screening in Children first appeared on HHM Global | B2B Online Platform & Magazine.